AI assistant
Lineage Cell Therapeutics Inc. — Director's Dealing 2012
Jul 3, 2012
6895_dirs_2012-07-03_476ef0c0-1f1b-4aa8-9116-2d77ad00788b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOTIME INC (BTX)
CIK: 0000876343
Period of Report: 2012-07-01
Reporting Person: LICHTINGER PEDRO (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-07-01 | Option to Purchase Common Shares | $4.60 | A | 20000 | Acquired | 2017-06-30 | Common Shares (20000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Shares, no par value | 6250 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Option to Purchase Common Shares | $5.13 | 2016-06-30 | Common Shares (20000) | 20000 | Direct |
| Option to Purchase Common Shares | $5.45 | 2015-08-09 | Common Shares (20000) | 20000 | Direct |
| Option to Purchase Common Shares | $3.45 | 2014-08-10 | Common Shares (20000) | 20000 | Direct |
Footnotes
F1: Does not include shares that may be acquired upon the exercise of certain stock options.
F2: 5,000 options will become exercisable on September 30, 2012; December 31, 2012; March 31, 2013; and June 30, 2013 based upon continued service on the board of directors.
F3: 5,000 options became exercisable on September 30, 2011; December 31, 2011; March 31, 2012; and June 30, 2012.
F4: 5,000 options became exercisable on September 30, 2010; December 31, 2010; March 31, 2011; and June 30, 2011.
F5: 5,000 options became exercisable on September 30, 2009; December 31, 2009; March 31, 2010; and June 30, 2010.